Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

US private equity firm Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit Mitsubishi Tanabe Pharma in a deal valued at approximately Y510bn ($3.3bn). The ...

BLACKSTONE is buying a company that helps drugmakers run clinical trials in Japan, adding to growing interest from private ...

Mitsubishi Tanabe Pharma is being sold to Bain Capital for about $3.3 billion. Eisai expects a Leqembi "expansion phase" on the horizon. And more. 1. Astellas shifts investment focus to later ...

Japan's Seven & I, the parent company of the Japanese 7-Eleven convenience store chain, says it is selling its supermarket ...

TOKYO -- U.S. private equity firm Bain Capital on Monday withdrew its planned bid to take over Japan's Fuji Soft, ending a battle to acquire the systems developer that had been raging with rival ...